FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386897817> ?p ?o ?g. }

• W4386897817 endingPage "e071330" @default.
• W4386897817 startingPage "e071330" @default.
• W4386897817 abstract "Objective Using glycated haemoglobin A1c (HbA1c) screening, we aimed to determine the prevalence of chronic dysglycaemia among patients with COVID-19 admitted to the intensive care unit (ICU). Additionally, we aimed to explore the association between chronic dysglycaemia and clinical outcomes related to ICU stay. Design Multicentre retrospective observational study. Setting ICUs in three hospitals in Stockholm, Sweden. Participants COVID-19 patients admitted to the ICU between 5 March 2020 and 13 August 2020 with available HbA1c at admission. Chronic dysglycaemia was determined based on previous diabetes history and HbA1c. Primary and secondary outcomes Primary outcome was the actual prevalence of chronic dysglycaemia (pre-diabetes, unknown diabetes or known diabetes) among COVID-19 patients. Secondary outcome was the association of chronic dysglycaemia with 90-day mortality, ICU length of stay, duration of invasive mechanical ventilation (IMV) and renal replacement therapy (RRT), accounting for treatment selection bias. Results A total of 308 patients with available admission HbA1c were included. Chronic dysglycaemia prevalence assessment was restricted to 206 patients admitted ICUs in which HbA1c was measured on all admitted patients. Chronic dysglycaemia was present in 82.0% (95% CI 76.1% to 87.0%) of patients, with pre-diabetes present in 40.2% (95% CI 33.5% to 47.3%), unknown diabetes in 20.9% (95% CI 15.5% to 27.1%), well-controlled diabetes in 7.8% (95% CI 4.5% to 12.3%) and uncontrolled diabetes in 13.1% (95% CI 8.8% to 18.5%). All patients with available HbA1c were included for the analysis of the relationship between chronic dysglycaemia and secondary outcomes. We found no independent association between chronic dysglycaemia and 90-day mortality, ICU length of stay or duration of IMV. After excluding patients with specific treatment limitations, no association between chronic dysglycaemia and RRT use was observed. Conclusions In our cohort of critically ill COVID-19 patients, the prevalence of chronic dysglycaemia was 82%. We found no robust associations between chronic dysglycaemia and clinical outcomes when accounting for treatment limitations." @default.
• W4386897817 created "2023-09-21" @default.
• W4386897817 creator A5004570094 @default.
• W4386897817 creator A5017109231 @default.
• W4386897817 creator A5023586963 @default.
• W4386897817 creator A5037426527 @default.
• W4386897817 creator A5072912292 @default.
• W4386897817 creator A5076918961 @default.
• W4386897817 creator A5079785311 @default.
• W4386897817 creator A5084263346 @default.
• W4386897817 date "2023-09-01" @default.
• W4386897817 modified "2023-10-03" @default.
• W4386897817 title "Prevalence and impact of chronic dysglycaemia among patients with COVID-19 in Swedish intensive care units: a multicentre, retrospective cohort study" @default.
• W4386897817 cites W1967397740 @default.
• W4386897817 cites W2059796825 @default.
• W4386897817 cites W3009885589 @default.
• W4386897817 cites W3013125498 @default.
• W4386897817 cites W3013283620 @default.
• W4386897817 cites W3015233121 @default.
• W4386897817 cites W3017792836 @default.
• W4386897817 cites W3023787531 @default.
• W4386897817 cites W3031959493 @default.
• W4386897817 cites W3041005642 @default.
• W4386897817 cites W3041985244 @default.
• W4386897817 cites W3048686971 @default.
• W4386897817 cites W3082064538 @default.
• W4386897817 cites W3083675354 @default.
• W4386897817 cites W3094263075 @default.
• W4386897817 cites W3102221846 @default.
• W4386897817 cites W3107133046 @default.
• W4386897817 cites W3111114305 @default.
• W4386897817 cites W3174715203 @default.
• W4386897817 cites W3193520262 @default.
• W4386897817 cites W3199017925 @default.
• W4386897817 cites W3203882870 @default.
• W4386897817 doi "https://doi.org/10.1136/bmjopen-2022-071330" @default.
• W4386897817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37730398" @default.
• W4386897817 hasPublicationYear "2023" @default.
• W4386897817 type Work @default.
• W4386897817 citedByCount "0" @default.
• W4386897817 crossrefType "journal-article" @default.
• W4386897817 hasAuthorship W4386897817A5004570094 @default.
• W4386897817 hasAuthorship W4386897817A5017109231 @default.
• W4386897817 hasAuthorship W4386897817A5023586963 @default.
• W4386897817 hasAuthorship W4386897817A5037426527 @default.
• W4386897817 hasAuthorship W4386897817A5072912292 @default.
• W4386897817 hasAuthorship W4386897817A5076918961 @default.
• W4386897817 hasAuthorship W4386897817A5079785311 @default.
• W4386897817 hasAuthorship W4386897817A5084263346 @default.
• W4386897817 hasBestOaLocation W43868978171 @default.
• W4386897817 hasConcept C126322002 @default.
• W4386897817 hasConcept C134018914 @default.
• W4386897817 hasConcept C167135981 @default.
• W4386897817 hasConcept C177713679 @default.
• W4386897817 hasConcept C187212893 @default.
• W4386897817 hasConcept C194828623 @default.
• W4386897817 hasConcept C201903717 @default.
• W4386897817 hasConcept C2776376669 @default.
• W4386897817 hasConcept C2777180221 @default.
• W4386897817 hasConcept C555293320 @default.
• W4386897817 hasConcept C71924100 @default.
• W4386897817 hasConceptScore W4386897817C126322002 @default.
• W4386897817 hasConceptScore W4386897817C134018914 @default.
• W4386897817 hasConceptScore W4386897817C167135981 @default.
• W4386897817 hasConceptScore W4386897817C177713679 @default.
• W4386897817 hasConceptScore W4386897817C187212893 @default.
• W4386897817 hasConceptScore W4386897817C194828623 @default.
• W4386897817 hasConceptScore W4386897817C201903717 @default.
• W4386897817 hasConceptScore W4386897817C2776376669 @default.
• W4386897817 hasConceptScore W4386897817C2777180221 @default.
• W4386897817 hasConceptScore W4386897817C555293320 @default.
• W4386897817 hasConceptScore W4386897817C71924100 @default.
• W4386897817 hasFunder F4320327237 @default.
• W4386897817 hasIssue "9" @default.
• W4386897817 hasLocation W43868978171 @default.
• W4386897817 hasLocation W43868978172 @default.
• W4386897817 hasOpenAccess W4386897817 @default.
• W4386897817 hasPrimaryLocation W43868978171 @default.
• W4386897817 hasRelatedWork W2042160336 @default.
• W4386897817 hasRelatedWork W2166971806 @default.
• W4386897817 hasRelatedWork W2281416424 @default.
• W4386897817 hasRelatedWork W2534023429 @default.
• W4386897817 hasRelatedWork W3092321312 @default.
• W4386897817 hasRelatedWork W3148396094 @default.
• W4386897817 hasRelatedWork W4296361120 @default.
• W4386897817 hasRelatedWork W4304166187 @default.
• W4386897817 hasRelatedWork W4322504283 @default.
• W4386897817 hasRelatedWork W4386328149 @default.
• W4386897817 hasVolume "13" @default.
• W4386897817 isParatext "false" @default.
• W4386897817 isRetracted "false" @default.
• W4386897817 workType "article" @default.